BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1850346)

  • 1. Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Sumitomo T; Suda T; Nakano Y; Tozawa F; Yamada M; Demura H
    Endocrinology; 1991 May; 128(5):2248-52. PubMed ID: 1850346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Suda T; Tozawa F; Iwai I; Sato Y; Sumitomo T; Nakano Y; Yamada M; Demura H
    Brain Res Mol Brain Res; 1993 Jun; 18(4):311-5. PubMed ID: 8392133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II and adrenocorticotropin release: mediation by endogenous corticotropin-releasing factor.
    Spinedi E; Rodriguez G
    Endocrinology; 1986 Sep; 119(3):1397-402. PubMed ID: 3015575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-induced hypoglycemia increases corticotropin-releasing factor messenger ribonucleic acid levels in rat hypothalamus.
    Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
    Endocrinology; 1988 Sep; 123(3):1371-5. PubMed ID: 2841092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus.
    Suda T; Sato Y; Sumitomo T; Nakano Y; Tozawa F; Iwai I; Yamada M; Demura H
    Endocrinology; 1992 Mar; 130(3):1325-30. PubMed ID: 1311237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-induced hypoglycemia increases proopiomelanocortin messenger ribonucleic acid levels in rat anterior pituitary gland.
    Tozawa F; Suda T; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
    Endocrinology; 1988 Apr; 122(4):1231-5. PubMed ID: 2831025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central administration of saikosaponin-d increases corticotropin-releasing factor mRNA levels in the rat hypothalamus.
    Dobashi I; Tozawa F; Horiba N; Sakai Y; Sakai K; Suda T
    Neurosci Lett; 1995 Sep; 197(3):235-8. PubMed ID: 8552307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus.
    Suda T; Tozawa F; Ushiyama T; Sumitomo T; Yamada M; Demura H
    Endocrinology; 1990 Feb; 126(2):1223-8. PubMed ID: 2153522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats.
    Jingami H; Matsukura S; Numa S; Imura H
    Endocrinology; 1985 Oct; 117(4):1314-20. PubMed ID: 2992910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats.
    Itoi K; Suda T; Tozawa F; Dobashi I; Ohmori N; Sakai Y; Abe K; Demura H
    Endocrinology; 1994 Nov; 135(5):2177-82. PubMed ID: 7956940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
    Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II increases ACTH release in the absence of endogenous arginine-vasopressin.
    Spinedi E; Negro-Vilar A
    Life Sci; 1984 Feb; 34(8):721-9. PubMed ID: 6321871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress.
    Harbuz MS; Rees RG; Eckland D; Jessop DS; Brewerton D; Lightman SL
    Endocrinology; 1992 Mar; 130(3):1394-400. PubMed ID: 1537299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levels after acute, but not chronic, daily "binge" intragastric alcohol administration.
    Zhou Y; Franck J; Spangler R; Maggos CE; Ho A; Kreek MJ
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1575-82. PubMed ID: 11045867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary.
    Levin N; Blum M; Roberts JL
    Endocrinology; 1989 Dec; 125(6):2957-66. PubMed ID: 2555132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of protein kinase-C-related adrenocorticotropin secretagogues and interleukin-1 on proopiomelanocortin gene expression in rat anterior pituitary cells.
    Suda T; Tozawa F; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Yamada M; Demura H; Shizume K
    Endocrinology; 1989 Mar; 124(3):1444-9. PubMed ID: 2537181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive corticotropin-releasing factor in rat plasma.
    Sumitomo T; Suda T; Tomori N; Yajima F; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Endocrinology; 1987 Apr; 120(4):1391-6. PubMed ID: 3030699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat.
    Schlussman SD; Zhou Y; Johansson P; Kiuru A; Ho A; Nyberg F; Kreek MJ
    Neurosci Lett; 2000 Apr; 284(3):190-4. PubMed ID: 10773431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.